These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12601498)

  • 1. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?
    Spaepen K; Stroobants S; Dupont P; Bormans G; Balzarini J; Verhoef G; Mortelmans L; Vandenberghe P; De Wolf-Peeters C
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):682-8. PubMed ID: 12601498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy.
    Brepoels L; Stroobants S; Vandenberghe P; Spaepen K; Dupont P; Nuyts J; Bormans G; Mortelmans L; Verhoef G; De Wolf-Peeters C
    J Nucl Med; 2007 Mar; 48(3):390-7. PubMed ID: 17332616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG and (18)F-FLT uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model.
    Brepoels L; Stroobants S; Verhoef G; De Groot T; Mortelmans L; De Wolf-Peeters C
    J Nucl Med; 2009 Jul; 50(7):1102-9. PubMed ID: 19525456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
    Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET.
    Brepoels L; De Saint-Hubert M; Stroobants S; Verhoef G; Balzarini J; Mortelmans L; Mottaghy FM
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1688-95. PubMed ID: 20461370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
    Krak NC; van der Hoeven JJ; Hoekstra OS; Twisk JW; van der Wall E; Lammertsma AA
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):674-81. PubMed ID: 12640556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model.
    Song SL; Liu JJ; Huang G; Wang ZH; Song YY; Sun XG; Chen T
    J Nucl Med; 2008 Feb; 49(2):303-9. PubMed ID: 18199614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
    Stahl A; Ott K; Schwaiger M; Weber WA
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1471-8. PubMed ID: 15257418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma.
    Riad R; Omar W; Sidhom I; Zamzam M; Zaky I; Hafez M; Abdel-Dayem HM
    Nucl Med Commun; 2010 Mar; 31(3):232-8. PubMed ID: 20032800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation.
    Bruechner K; Bergmann R; Santiago A; Mosch B; Yaromina A; Hessel F; Hofheinz F; van den Hoff J; Baumann M; Beuthien-Baumann B
    Int J Radiat Biol; 2009 Sep; 85(9):772-80. PubMed ID: 19657862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-modality monitoring of tumor response to cyclophosphamide therapy in mice with bioluminescence imaging and small-animal positron emission tomography.
    Ma X; Liu Z; Yang X; Gao Q; Zhu S; Qin C; Liu K; Zhang B; Han D; Wang F; Tian J
    Mol Imaging; 2011 Aug; 10(4):278-83. PubMed ID: 21501569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Haematologica; 2000 Jun; 85(6):613-8. PubMed ID: 10870118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imaging.
    Rybczynska AA; de Bruyn M; Ramakrishnan NK; de Jong JR; Elsinga PH; Helfrich W; Dierckx RA; van Waarde A
    J Nucl Med; 2013 Sep; 54(9):1613-20. PubMed ID: 23940303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.
    Yamane T; Daimaru O; Ito S; Yoshiya K; Nagata T; Ito S; Uchida H
    J Nucl Med; 2004 Nov; 45(11):1838-42. PubMed ID: 15534052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
    Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
    Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
    Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
    Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.